News

Published on 3 May 2024 on Zacks via Yahoo Finance

IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?


Article preview image

Wall Street expects a year-over-year increase in earnings on higher revenues when IGM Biosciences, Inc. (IGMS) reports results for the quarter ended March 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock may move lower.

NASDAQ.IGMS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Shareholders May Find It Hard To Justify Increasing IGM Biosciences, Inc.'s...

Key Insights IGM Biosciences' Annual General Meeting to take place on 11th of June Salary of...

Simply Wall St. ยท via Yahoo Finance 23 May 2024

IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates

IGM Biosciences, Inc. (IGMS) came out with a quarterly loss of $0.83 per share versus the Zacks C...

Zacks via Yahoo Finance 9 May 2024

IGM Biosciences Inc (IGMS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Clinical ...

Revenue: Reported Q1 2024 collaboration revenue of $0.5 million, falling short of the estimated $...

GuruFocus.com via Yahoo Finance 8 May 2024

IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street expects a year-over-year increase in earnings on higher revenues when IGM Biosciences...

Zacks via Yahoo Finance 3 May 2024

IGM Biosciences Insiders Placed Bullish Bets Worth US$992.2k

Over the last year, a good number of insiders have significantly increased their holdings in IGM ...

Simply Wall St. via Yahoo Finance 19 Apr 2024

IGM Biosciences executive sells over $9,000 in stock By Investing.com

In recent trading activity, Steven Weber, the Principal Accounting Officer of IGM Biosciences, In...

Investing.com 16 Mar 2024

Igm biosciences executive sells over $54k in company stock By Investing.com

In recent trading activity, Chris H. Takimoto, the Chief Medical Officer of IGM Biosciences, Inc....

Investing.com 16 Mar 2024

Igm biosciences CFO sells over $54k in company stock

Investors following IGM Biosciences, Inc. (NASDAQ: IGMS ) should note that the company's Chief Fi...

Investing.com 15 Mar 2024

IGM Biosciences' chief scientific officer sells over $39k in company stock

IGM Biosciences, Inc. (NASDAQ: IGMS ) has reported that its Chief Scientific Officer, Bruce Keyt,...

Investing.com 15 Mar 2024

IGM Biosciences CEO sells shares worth over $89k

IGM Biosciences, Inc. (NASDAQ: IGMS ) has reported a recent sale of company stock by CEO and Pres...

Investing.com 15 Mar 2024